Recent Updates
Recently added Catalysts
PEN

Penumbra, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 40th Annual J.P. Morgan Healthcare Conference on...

Key Takeaway: ALAMEDA, Calif. , Dec. 22, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that its management team is scheduled to present at the 40 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 . Event: 40 th Annual J.P. Morgan Healthcare Conference

Full Press Release Details

ALAMEDA, Calif. , Dec. 22, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that its management team is scheduled to present at the 40 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 .
Event: 40 th Annual J.P. Morgan Healthcare Conference Date: Tuesday, January 11, 2022 Time: 11:15am ET / 8:15am PT
An audio webcast of the presentation will be available by visiting the investors' section of the company's website at www.penumbrainc.com . The audio webcast will be available on the company's website for at least two weeks following the event.
About Penumbra Penumbra, Inc., headquartered in Alameda, California , is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. The Penumbra logo is a trademark of Penumbra, Inc. For more information, visit www.penumbrainc.com .
Investor Relations Penumbra, Inc. 510-995-2461 [email protected]
SOURCE Penumbra, Inc.

Related Links

21 %

Last updated: Dec 22, 2021